KR101798791B1 - The manufacturing method for rice with enhanced resistant starch - Google Patents
The manufacturing method for rice with enhanced resistant starch Download PDFInfo
- Publication number
- KR101798791B1 KR101798791B1 KR1020160159548A KR20160159548A KR101798791B1 KR 101798791 B1 KR101798791 B1 KR 101798791B1 KR 1020160159548 A KR1020160159548 A KR 1020160159548A KR 20160159548 A KR20160159548 A KR 20160159548A KR 101798791 B1 KR101798791 B1 KR 101798791B1
- Authority
- KR
- South Korea
- Prior art keywords
- rice
- starch
- weight
- present
- content
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 65
- 235000009566 rice Nutrition 0.000 title claims abstract description 65
- 229920000294 Resistant starch Polymers 0.000 title abstract description 26
- 235000021254 resistant starch Nutrition 0.000 title abstract description 26
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 240000007594 Oryza sativa Species 0.000 title description 55
- 241000209094 Oryza Species 0.000 claims abstract 10
- 238000000576 coating method Methods 0.000 claims description 42
- 239000011248 coating agent Substances 0.000 claims description 41
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 26
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 26
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 13
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 13
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 13
- 229940076810 beta sitosterol Drugs 0.000 claims description 13
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 13
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 13
- 229950005143 sitosterol Drugs 0.000 claims description 13
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 13
- 235000016831 stigmasterol Nutrition 0.000 claims description 13
- 229940032091 stigmasterol Drugs 0.000 claims description 13
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 13
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 12
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 12
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 12
- 235000000431 campesterol Nutrition 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 229940076279 serotonin Drugs 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 5
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 2
- 235000012054 meals Nutrition 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 description 41
- 235000019698 starch Nutrition 0.000 description 41
- 239000008107 starch Substances 0.000 description 40
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 23
- 235000012000 cholesterol Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 229920000856 Amylose Polymers 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910021421 monocrystalline silicon Inorganic materials 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/196—Products in which the original granular shape is maintained, e.g. parboiled rice
- A23L7/1963—Products in which the original granular shape is maintained, e.g. parboiled rice coated with a layer
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2136—Phytosterols, phytostanols
- A23V2250/21364—Campesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2136—Phytosterols, phytostanols
- A23V2250/21372—Sitosterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2136—Phytosterols, phytostanols
- A23V2250/21376—Stigmasterol
Abstract
Description
본 발명은 저항성 전분 함량이 향상된 쌀의 제조방법에 관한 것이다.The present invention relates to a method for producing rice with improved resistance starch content.
전분(starch)은 대부분의 식물에 널리 분포하고 있는 중요한 저장물질이다. 전분은 긴 사슬로 구성된 탄수화물로서 요오드화칼륨 액에 흑청색으로 염색되어 압자상의 전분립으로 나타난다. 광합성에 의해서 최초로 만들어진 엽록체 속의 전분을 동화전분(assimilation starch)라 하고 이에 대해서 저장기관에 저장되어 있는 전분을 저장전분(reserve starch)이라 한다. 그리고 동화전분이나 저장전분이 다른 조직으로 옮겨질 때는 이동하는 도중에 일시적으로 저장되는 수가 있어서 이것을 다종전분(transitory starch)이라고 한다. Starch is an important storage material that is widely distributed in most plants. Starch is a long chain carbohydrate that is stained with a potassium iodide solution in black blue and appears as a starch phase on the indenter. The starch in the chloroplast first made by photosynthesis is called assimilation starch and the starch stored in the storage organ is called the reserve starch. And, when the assimilated starch or stored starch is transferred to another tissue, it can be stored temporarily during the movement, which is called a transitory starch.
사람이 이용하고 있는 전분은 모두 저장전분이고 감자의 덩이줄기, 고구마의 덩이뿌리, 종자, 과실 등은 전문적인 저장기관이며 않은 양의 전분을 저장하고 있다. The starch used by a person is all stored starch, and potato tuber, sweet potato root, seed, and fruit are professional storage organisms and store unheated starch.
저항전분이란, 섭취한 전분 중의 일부는 소화되지 않는 경우가 있는데, 이를 저항전분(resistant starch, RS)이라고 한다. 소화가 되지 않는 이유는 첫째, 현미처럼 곡식이 일부분만 도정되거나 작은 낟알로 존재할 때 아밀라아제가 작용하지 못하기 때문이고, 두 번째는 전분이 부분적으로 호화되지 않은 경우에 효소 작용이 불가능하기 때문이며, 세 번째는 호화가 다 되었으나 음식이 식어 노화과정을 거치는 동안 전분 구조가 젤라틴 형태로 되어 소화 효소의 효율이 감소하거나 불가능해지기 때문이다. 이와 같이 소화기장에서 소화가 되지 않은 전분은 마치 식이 섬유와 같은 작용을 하여 대장에서 박테리아에 의해 발효가 일어난다. 식품 중에 함유된 저항 전분의 양은 급원, 숙성 정도, 도정 정도, 낟알의 마쇄 정도, 가공과정, 조리 및 보관 방법에 의해 영향을 받으며, 입에서 저장작용이 많이 일어날수록 그 양이 감소한다. 저항 전분의 중요성은 식이 섬유와 같은 작용을 하므로 당뇨병. 비만. 관상동맥 질환에 이점을 줄 수 있으며, 1g의 저항전분은 약 2.15~2.34kcal의 열량을 내므로 체중 감량제로서 사용할 수 있다는 것이다. Resistant starch means that some of the starch ingested is not digested, which is called resistant starch (RS). The reason for not being digested is as follows: First, amylase does not work when grain is partially processed, such as brown rice, or when it exists as small grain. Second, enzyme activity is impossible when starch is not partially hydrolyzed. The starch structure becomes gelatinous during the aging process and the efficiency of the digestive enzymes decreases or becomes impossible. As such, starch that is not digested in the digestive system acts like dietary fiber, and fermentation takes place by bacteria in the large intestine. The amount of the resistant starch contained in the food is affected by the source, the degree of aging, the degree of grinding, the degree of grinding of the kernel, the processing process, the cooking and storage method, The importance of resistant starch acts like dietary fiber, so diabetes. obesity. Coronary artery disease, and 1 g of resistant starch can be used as a weight loss agent since it produces about 2.15 to 2.34 kcal of calories.
저항전분(Resistant starch, 이하 RS)은 4종류로 분류되고 있다. RS1은 효소와 만나기 어려운 전분, RS2는 감자, 바나나 전분, 고아밀로오스 옥수수전분 같은 B-형의 결정형을 가지는 생전분을 의미하며, 입자 형태를 유지하고 있지만 가열하면 효소에 대한 저항성을 소실되므로 조리나 가공 식품과 같이 가열 처리하는 식품에 사용할 수 없는 형태이다. 일 예로, R2 함량을 증가시키기 위한 방법을 한국공개특허 제2004-0065072호에 게재한 바 있다. 상기 한국공개특허 제2004-0065072호에서는 가교결합 전분 제조시 전분에 산처리와 열처리를 병행하여 RS 함량을 증가시킬 수 있다는 내용이 기재되어 있다. 반면에 RS3는 가열에 의해 호화된 전분이 노화된 것으로 아밀로오스 함량이 높을수록 RS 수율이 증가된다. 현재 미국과 유럽에서는 전분을 분지하고 가열냉각 과정을 거친 노브로스(Novelose) 330과 크리스타린(Crystalean)이 생산되고 있는데, 생전분 입자와 같은 형태를 유지하지 못하며 가열에 의해 일부가 무정형으로 바뀌어 수분을 가하면 생전분에 비해 흡수율이 증가되는 특징이 있다. 일단 흡수된 RS3 전분은 가열에 의해 더 이상의 부피증가는 없으므로 조리, 가공 중에 안정한 구조를 가질 수 있다. 화학적인 변성에 의해 만들어진 전분도 효소에 저항성을 갖는데 이는 RS4로 불리운다. RS4는 가교결합에 의해 생전분과 같은 입자형태를 나타내며, 제조방법에 따라 팽윤력이 다른 것을 얻을 수 있다. 가교결합(Cross-linking), 에스테르화(esterification), 에테르화(eterification), 린트너리제이션(lintnerization) 등의 화학적 처리에 의해 RS4 형태의 전분을 제조할 수 있으며 특히 가교결합(cross-linking)처리하여 만든 화학적 변성전분인 RS4 전분이 알려지면서 새로운 형태의 RS를 개발하려는 연구가 지속적으로 이루어지고 있다. 일 예로는, 한국공개특허 제2002-0070671호에서 생전분을 어닐링 처리하고 계면활성제를 첨가함으로써 저항전분의 수율이 증가되고 분쇄가 용이한 RS4 형태의 가교결합 저항전분이 기재되어 있다.Resistant starch (RS) is classified into four types. RS1 means a starch which is difficult to meet the enzyme, RS2 means a raw starch having a crystal form of B-type such as potato, banana starch and high amylose corn starch, and since the resistance to the enzyme is lost when heated, It is a form that can not be used for foods to be heated such as processed foods. For example, a method for increasing the R2 content is disclosed in Korean Patent Publication No. 2004-0065072. Korean Patent Laid-Open Publication No. 2004-0065072 discloses that the RS content can be increased by adding acid treatment and heat treatment to starch in preparing crosslinked starch. RS3, on the other hand, is the starch aged by heating. The higher the amylose content, the higher the RS yield. Currently, the US and Europe are producing Novelose 330 and Crystalean, which are branched from starch and subjected to heating and cooling processes. They do not maintain the same shape as raw starch particles, and some become amorphous by heating, The absorption rate is increased compared to the live mass. Once the absorbed RS3 starch has no further volume increase by heating, it can have a stable structure during cooking and processing. Starch, made by chemical modification, is also resistant to enzymes, called RS4. RS4 exhibits a particle shape such as a viable powder by crosslinking, and the swelling power can be different depending on the production method. RS4 type starches can be prepared by chemical treatments such as cross-linking, esterification, etherification and lintnerization, and cross-linking RS4 starch, which is a chemical modified starch, has been known. For example, in Korean Patent Publication No. 2002-0070671, crosslinked resistive starch having an RS4 form in which a raw starch powder is annealed and a surfactant is added to increase the yield of resistant starch and to facilitate crushing is disclosed.
따라서, 본 발명의 발명자는 저항 전분에 관하여 연구하던 중 저항성 전분 함량을 향상시킬 수 있는 쌀을 개발하기에 이르렀다.Therefore, the inventors of the present invention have developed rice which can improve the content of resistant starch during research on resistant starch.
본 발명은 저항성 전분의 함량을 향상시킬 수 있는 코팅액을 쌀의 표면에 코팅하여 쌀을 제조하는 방법을 제공하는데 그 목적이 있다.It is an object of the present invention to provide a method for preparing rice by coating a surface of rice with a coating solution capable of improving the content of resistant starch.
본 발명의 적절한 실시 형태에 따르면, 스티그마스테롤, 베타시토스테롤, 캄페스테롤 및 세로토닌 중 적어도 하나를 포함하는 코팅액을 준비하는 단계; 상기 코팅액을 레이저 처리하는 단계; 및 쌀의 표면에 상기 코팅액을 코팅하되, 쌀과 코팅액은 1 : 0.01 내지 0.5 중량비로 코팅하는 단계를 포함하는 것을 특징으로 한다.According to a preferred embodiment of the present invention, there is provided a method for preparing a pharmaceutical composition comprising the steps of: preparing a coating liquid containing at least one of stigmasterol, betasitosterol, campesterol and serotonin; Laser treating the coating solution; And coating the coating solution on the surface of the rice, wherein the coating solution is coated at a weight ratio of 1: 0.01 to 0.5.
또한, 상기 스티그마스테롤 100 중량부에 대하여, 상기 베타시토스테롤은 5 내지 150 중량부, 상기 캄페스테롤롤은 50 내지 200 중량부 및 상기 세로토닌은 5 내지 150 중량부를 포함하는 것을 특징으로 한다.The beta-sitosterol may be contained in an amount of 5 to 150 parts by weight, the campesterol may be 50 to 200 parts by weight, and the serotonin may be added in an amount of 5 to 150 parts by weight based on 100 parts by weight of the stigmasterol.
또한, 상기 상기 레이저 처리의 파장은 1,040 내지 1,056nm이고, 주파수는 5.2 내지 5.6Hz인 것을 특징으로 한다.The wavelength of the laser treatment is 1,040 to 1,056 nm and the frequency is 5.2 to 5.6 Hz.
또한, 본 발명은 상기 코팅된 쌀의 수분 함량이 15 내지 18중량%가 되도록 건조하는 단계를 더 포함하는 것을 특징으로 한다.Further, the present invention is characterized by further comprising drying the coated rice so that the moisture content of the coated rice is 15 to 18% by weight.
본 발명에 의한 쌀의 제조방법은 쌀의 저항성 전분의 함량을 향상시킬 수 있는 효과를 가진다.The method for producing rice according to the present invention has an effect of improving the content of resistant starch of rice.
또한, 본 발명은 쌀 표면에 코팅된 유효성분이 박리되지 않고 장기간 저장 가능한 효과를 가진다.Further, the present invention has the effect that the active ingredient coated on the rice surface can be stored for a long period without being peeled off.
또한, 본 발명에 의해 제조된 쌀을 이용하여 밥을 지어 섭취할 경우, 당뇨환자의 혈당을 감소시키고, 저칼로리 식단으로 당뇨환자에게 도움을 주며, 쌀밥의 맛과 풍미를 증진시킬 수 있는 효과를 가진다.In addition, when rice prepared by using the rice produced by the present invention is cooked, the blood sugar of a diabetic patient is reduced, the diabetic patient is assisted by a low-calorie diet, and the taste and flavor of rice can be improved .
이하, 본 발명에 대하여 상세히 설명하기로 한다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시예에 기재된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.Hereinafter, the present invention will be described in detail. Prior to this, terms and words used in the present specification and claims should not be construed as limited to ordinary or dictionary terms, and the inventor should appropriately interpret the concepts of the terms appropriately It should be interpreted in accordance with the meaning and concept consistent with the technical idea of the present invention based on the principle that it can be defined. Therefore, the constitutions described in the embodiments described herein are merely the most preferred embodiments of the present invention, and are not intended to represent all of the technical ideas of the present invention. Therefore, various equivalents which can be substituted at the time of application It should be understood that variations can be made.
본 발명에 따른 저항성 전분 함량이 향상된 쌀의 제조방법은,A method for producing rice with improved resistance starch content according to the present invention comprises:
스티그마스테롤, 베타시토스테롤, 캄페스테롤 및 세로토닌 중 적어도 하나를 포함하는 코팅액을 준비하는 단계; Preparing a coating liquid containing at least one of stigmasterol, beta-sitosterol, campesterol, and serotonin;
상기 코팅액을 레이저 처리하는 단계; 및Laser treating the coating solution; And
쌀의 표면에 상기 코팅액을 코팅하되, 쌀과 코팅액은 1 : 0.01 내지 0.5 중량비로 코팅하는 단계를 포함하는 것을 특징으로 한다.Coating the surface of the rice with the coating solution, and coating the rice and the coating solution at a weight ratio of 1: 0.01 to 0.5.
하기에, 본 발명의 쌀의 제조방법을 상세하게 설명하기로 한다.Hereinafter, the method for producing rice of the present invention will be described in detail.
우선, 스티그마스테롤, 베타시토스테롤, 캄페스테롤 및 세로토닌 중 적어도 하나를 포함하는 코팅액을 준비한다.First, a coating solution containing at least one of stigmasterol, betasitosterol, campesterol, and serotonin is prepared.
여기서, 상기 스티그마스테롤(Stigmasterol)은 약 40nm의 평균 입경을 가지며, 곁사슬에 이중 결합을 갖는 식물성 스테롤(phytosterol)의 일종으로 각종 스테로이드호르몬의 합성재제로서도 사용된다. 화학식은 C29H48O 이고 분자량은 412.691, 융점 170℃로서 22번과 23번 탄소사이에 이중결합을 가진다는 점에서 콜레스테롤과 구별된다. 또한, 대두 스테롤(sterol)의 약 25%, 강낭콩, 야자기름이나 채종유, 맥문동(Ophiopogon japonicus) 등의 식물 종자나 두류, 견과류, 채소류, 생우유에 널리 들어 있다. 대두의 불검화물에서부터 추출, 정제되는 스테롤로서 호르몬 합성의 원료로서 이용될 수 있다. 또한, 상기 스티그마스테롤은 콜레스테롤 수치를 저하시키는데 효과적이며 그 밖에 암, 골격의 동통, 견비통, 신경통, 해열, 진통, 협통 등의 치료에도 효과적이다.The stigmasterol is a phytosterol having an average particle size of about 40 nm and having a double bond in the side chain. The stigmasterol is also used as a synthesis agent for various steroid hormones. Formula is C 29 H 48O molecular weight has a double bond between 22 and 23 times as carbon 412.691, melting point 170 ℃ is distinct from the cholesterol in the point. It is also widely distributed in plant seeds and beans, nuts, vegetables, and raw milk, such as about 25% of soy sterols, kidney beans, palm oil and seed oil, and Ophiopogon japonicus. It can be used as a raw material for hormone synthesis as a sterol that is extracted and purified from unsaponifiables of soybeans. In addition, the stigmasterol is effective for lowering the cholesterol level, and is also effective for treatment of cancer, skeletal pain, stiffness, neuralgia, fever, pain, tightness and the like.
또한, 상기 베타시토스테롤(Beta-sitosterol)은 파이토스테롤(phytosterols)의 일종으로서 약 40nm의 평균 입경을 가지며, 그 구조는 콜레스테롤과 유사하나 에틸기에 따라 콜레스테롤과 다르다. 대부분의 식물에 풍부하게 들어 있으며, 쌀겨, 땅콩, 콩류, 호박씨, 옥수수유, 무, 배추, 구기자 등에 많이 들어 있다. 화학식은 C29H50O이고, 분자량은 414이고, 물이나 지용성 용매에 잘 녹지 않아 의약품에만 주로 사용되어 왔다. 그러나, 자연에서 발견되는 형태는 주로 에스터 또는 글리코시드 형태로서 두 형태 모두 베타시토스테롤 자체보다 용해가 잘 되는 편이다. 또한, 베타시토스테롤은 혈액 내 콜레스테롤 감소 및 항암, 면역증강 효과 외에도 대장암과 전립선 비대증에 효과적이며 제2형 당뇨병 환자의 혈당을 조절하는 데 효과적이다. 베타시토스테롤 성분은 혈액에 콜레스테롤이 침착하는 것을 억제하여 심혈관 기능을 높여 주는 역할을 하는데, 저밀도 지방단백질(Low density Lipoprotein: LDL)과 경쟁적으로 작용하여 인체 내 콜레스테롤의 흡수를 저해한다. 또한, 암세포의 자살(apoptosis)을 유도하여 암세포의 증식을 억제한다. 이외에도 항궤양, 항균, 항염증, 항산화 효과 등이 있다.The beta-sitosterol is a type of phytosterols having an average particle size of about 40 nm, and its structure is similar to that of cholesterol but is different from cholesterol according to the ethyl group. It is abundant in most plants, and it is abundant in rice bran, peanut, beans, pumpkin seed, corn oil, radish, cabbage, The chemical formula is C 29 H 50 O and its molecular weight is 414, which is not well soluble in water or a fat-soluble solvent and has been mainly used in pharmaceuticals. However, the forms found in nature are mainly in the form of esters or glycosides, both of which are more soluble than beta-sitosterol itself. In addition, beta - sitosterol is effective in reducing blood cholesterol, anti - cancer and immune - enhancing effects as well as in colorectal cancer and benign prostatic hyperplasia, and is effective in controlling blood glucose levels in patients with type 2 diabetes. The beta-sitosterol component plays a role in enhancing cardiovascular function by inhibiting the accumulation of cholesterol in the blood. It competes with low density lipoprotein (LDL) and inhibits the absorption of cholesterol in the human body. In addition, it induces apoptosis of cancer cells and inhibits the proliferation of cancer cells. In addition, there are anti-ulcer, anti-bacterial, anti-inflammatory and antioxidant effects.
또한, 상기 캄페스테롤(Campesterol)은 약 80nm의 평균 입경을 가지고, 식물스테롤이라고 하며, 화학적으로 콜레스테롤과 유사하다. 캄페스테롤은 side chain의 24th carbon 자리에 메틸그룹이 존재하는 것이 콜레스테롤과 다르며, cholestane 계열의 4-desmethylsterols로서 분류되어 진다. 화학식은 C28H48O 이고, 분자량이 400.68 이며, 콩 및 대두식물 종자 및 해바라기씨에 존재한다. 상기 캄페스테롤은 Total-콜레스테롤과, 담즙산염으로 콜레스테롤을 치환하거나 장점막에서 콜레스테롤 에스테르화 억제를 통하여 LDL-콜레스테롤 수치를 낮추어 관상심장질환의 위험을 줄이는 데 효과적이다. 또한, 캄페스테롤은 식이 콜레스테롤 흡수와 위장관의 내생적인 콜레스테롤 재흡수를 억제하고, 콜레스테롤을 변으로 배설하여 세럼 콜레스테롤 수치를 줄이는 데 효과적이다.The campesterol has an average particle size of about 80 nm, is called plant sterol, and chemically similar to cholesterol. Camptesterol is classified as cholestane-based 4-desmethylsterols in that the presence of a methyl group at the 24th carbon site of the side chain is different from that of cholesterol. Formula is C 28 H 48O, and the molecular weight is 400.68, and the soy beans are present in plant seeds and sunflower seeds. The campesterol is effective in reducing the risk of coronary heart disease by lowering LDL-cholesterol levels by replacing cholesterol with total-cholesterol and bile acid salts or inhibiting cholesterol esterification in the intestinal mucosa. In addition, campesterol is effective in suppressing dietary cholesterol absorption and endogenous cholesterol reabsorption of the gastrointestinal tract and reducing serum cholesterol levels by excretion of cholesterol into the feces.
또한, 상기 세로토닌(Serotonin)은 약 80nm의 평균 입경을 가지며, 뇌의 시상하부 중추에 존재하는 신경전달물질 중 하나이다. 아미노산인 트립토판에서 유도된 화학물질로서, 혈액이 응고할 때 혈소판으로부터 혈청 속으로 방출되는 혈관 수축작용을 하는 물질이다. 뇌ㆍ내장조직ㆍ혈소판(血小板)ㆍ비만세포에 들어 있으며, 5-하이드록시트립타민이라고도 한다. 세로토닌은 기분을 조절할 뿐만 아니라, 식욕, 수면, 근수축과 관련한 많은 기능에 관여한다. 또한, 사고기능과 관련하기도 하는데 기억력, 학습에 영향을 미치며, 혈소판에 저장되어 지혈과 혈액응고 반응에 관여한다. 따라서, 세로토닌이 모자라면 우울증, 불안증 등이 생긴다. 또한, 식욕 및 음식물 선택에 있어서 중요한 조절자로 작용하며 탄수화물 섭취와 가장 관련이 있다. 국소적으로 세로토닌이 증가하면 식욕이 떨어지게 되고, 감소할 경우에는 반대 현상이 나타난다.The serotonin has an average particle size of about 80 nm and is one of the neurotransmitters present in the hypothalamus of the brain. It is a chemical substance derived from tryptophan which is an amino acid, and is a substance that acts as a vasoconstrictor that is released into the serum from platelets when blood coagulates. It is contained in the brain, visceral tissues, platelets, and mast cells, and is also called 5-hydroxytryptamine. Serotonin not only controls mood, but is involved in many functions related to appetite, sleep, and muscle contraction. It is also associated with thinking function, which affects memory and learning, and is stored in platelets and is involved in hemostasis and blood coagulation. Therefore, when serotonin is inadequate, it causes depression and anxiety. It also acts as an important regulator of appetite and food choices and is most linked to carbohydrate intake. Increased serotonin locally causes appetite to decline, and declines in the opposite direction.
또한, 상기 스티그마스테롤 100 중량부에 대하여, 상기 베타시토스테롤은 바람직하게는 5 내지 150 중량부를 포함할 수 있고, 더욱 바람직하게는 10 내지 100 중량부를 포함할 수 있으며, 가장 바람직하게는 30 내지 80 중량부를 포함할 수 있다. 여기서, 상기 베타시토스테롤은 기재된 함량 미만으로 포함할 경우, 저항성 전분을 증가시킬 수 없고, 기재된 함량을 초과하여 포함할 경우 용해성이 떨어지는 문제점이 있다.The β-sitosterol may include 5 to 150 parts by weight, more preferably 10 to 100 parts by weight, and most preferably 30 to 80 parts by weight, based on 100 parts by weight of the stigmasterol. Section. Herein, when the beta-sitosterol is contained in an amount less than the stated content, the resistant starch can not be increased, and when it is contained in an amount exceeding the stated content, the solubility is deteriorated.
또한, 상기 스티그마스테롤 100 중량부에 대하여, 상기 캄페스테롤은 바람직하게는 50 내지 200 중량부를 포함할 수 있고, 더욱 바람직하게는 80 내지 150 중량부를 포함할 수 있으며, 가장 바람직하게는 90 내지 120 중량부를 포함할 수 있다. 여기서, 상기 캄페스테롤은 기재된 함량 미만으로 포함할 경우, 저항성 전분을 증가시킬 수 없고, 기재된 함량을 초과하여 포함할 경우 용해성이 떨어지는 문제점이 있다.The camphesterol may preferably contain 50 to 200 parts by weight, more preferably 80 to 150 parts by weight, and most preferably 90 to 120 parts by weight, based on 100 parts by weight of the stigmasterol. Section. Herein, when the campesterol is contained in an amount less than the stated content, the resistant starch can not be increased, and when it is contained in an amount exceeding the stated content, the solubility is poor.
또한, 상기 스티그마스테롤 100 중량부에 대하여, 상기 세로토닌은 바람직하게는 5 내지 150 중량부를 포함할 수 있고, 더욱 바람직하게는 10 내지 100 중량부를 포함할 수 있으며, 가장 바람직하게는 30 내지 80 중량부를 포함할 수 있다. 여기서, 상기 캄페스테롤은 기재된 함량 미만으로 포함할 경우, 쌀의 풍미가 저하되고 저항성 전분을 증가시킬 수 없으며, 기재된 함량을 초과하여 포함할 경우 소화가 힘들어진다.In addition, for 100 parts by weight of the stigmasterol, the serotonin may preferably comprise 5 to 150 parts by weight, more preferably 10 to 100 parts by weight, and most preferably 30 to 80 parts by weight . Here, when the campesterol is contained in an amount less than the stated content, the flavor of the rice is lowered and the resistant starch can not be increased. When the content exceeds the above-mentioned content, digestion becomes difficult.
다음으로, 앞서 준비된 코팅액을 레이저로 조사한다.Next, the coating solution prepared above is irradiated with a laser.
여기서, 레이저 조사시 파장은 1,040 내지 1,056nm이고, 주파수는 5.2 내지 5.6Hz이며, 평균 출력 광전력은 85 내지 95W인 것이 바람직하다. 상기에 기재한 범위 내에서 레이저 조사할 경우 코팅액이 초자성 나노입자 성질을 띄어 응집력이 높아지므로, 쌀에 코팅시 코팅 효율이 높아지는 장점을 가진다. 또한, 레이저 조사한 코팅액을 쌀의 표면에 코팅시킬 경우, 6 내지 12개월 동안 표면 박리 없이 유지할 수 있는 장점을 가진다.Here, it is preferable that the laser beam has a wavelength of 1,040 to 1,056 nm, a frequency of 5.2 to 5.6 Hz, and an average output optical power of 85 to 95 W. When the laser is irradiated within the range described above, the cohesive force of the coating solution becomes higher due to the supermagnetic nanoparticle properties, which has an advantage of increasing the coating efficiency upon coating with rice. In addition, when the coating solution for laser irradiation is coated on the surface of rice, it has an advantage that it can be maintained without surface peeling for 6 to 12 months.
또한, 레이저 조사는 2분 내지 10분 동안 조사하는 것이 바람직하다.The laser irradiation is preferably conducted for 2 to 10 minutes.
레이저 조사한 상기 코팅액은 분산 용매로 물과 함께 혼합할 수 있으며, 상기 코팅액과 물은 500 내지 1,500 : 1의 중량비로 혼합되는 것이 바람직하다. 여기서, 상기 물에 대하여 코팅액의 함량이 기재된 함량 미만으로 포함할 경우, 저항성 전분의 효과 증진에 영향을 미칠 수 없고, 상기 코팅액의 함량이 기재된 함량을 초과하여 포함할 경우, 용매 내에 침전되어 쌀의 표면에 고르게 코팅이 어려운 문제점이 발생한다.The laser-irradiated coating solution may be mixed with water in a dispersion solvent, and the coating solution and water are preferably mixed at a weight ratio of 500 to 1,500: 1. If the content of the coating liquid is less than the content described above, the effect of the resistant starch can not be improved. If the content of the coating liquid exceeds the content described above, It is difficult to uniformly coat the surface.
다음으로, 앞서 준비된 코팅액을 쌀의 표면에 코팅하여 저항성 전분 함량이 강화된 쌀을 얻는다.Next, the coating solution prepared above is coated on the surface of rice to obtain rice with a high resistance starch content.
여기서, 코팅 대상인 쌀은 현미 또는 백미를 미리 세척처리하여 얻어진 청결미를 사용할 수 있다. 코팅하기 전에 쌀은 50 내지 80℃로 건조하여, 수분 함량이 15 내지 25중량%가 되도록 건조하는 것이 바람직하다. 이때 건조는 자연건조 또는 열풍건조에 의하여 이루어지는 것이 바람직하다.Here, the rice to be coated can be cleanliness obtained by washing the brown rice or white rice beforehand. Before coating, the rice is preferably dried at 50 to 80 캜 and dried to have a water content of 15 to 25% by weight. In this case, drying is preferably carried out by natural drying or hot air drying.
그리고, 준비된 쌀의 표면에 상기 코팅액을 코팅하는 것을 특징으로 한다. 코팅하는 방법으로는 상기 코팅액에 쌀을 침지시키거나, 분사하는 방식 등을 들 수 있다.Then, the coating liquid is coated on the surface of the prepared rice. Examples of the coating method include a method of immersing or spraying rice in the coating solution.
여기서, 상기 쌀과 상기 코팅액은 1 : 0.01 내지 0.5 중량비로 코팅하는 것이 바람직하며, 가장 바람직하게는 1: 0.01 내지 0.2 중량비로 코팅할 수 있다. 상기에 기재된 중량비로 코팅하는 경우, 쌀의 표면에 고르게 코팅될 수 있으며 저항성 전분 함량을 극대화시킬 수 있다.The rice and the coating liquid are preferably coated at a weight ratio of 1: 0.01 to 0.5, and most preferably 1: 0.01 to 0.2. When coated at the weight ratio described above, it can be uniformly coated on the surface of rice and maximize the content of resistant starch.
또한, 상기 코팅액을 쌀의 표면에 코팅하는 경우, 1회 이상 코팅할 수 있다.When the coating solution is coated on the surface of rice, it may be coated more than once.
일 예로, 코팅액을 쌀 중량대비 0.06 중량부를 쌀의 표면에 1회 코팅한 다음 이어 코팅액을 쌀 중량대비 0.06 중량부를 쌀의 표면에 1회 더 추가로 코팅할 수 있다.For example, 0.06 part by weight of the coating liquid may be coated once on the surface of the rice, and the coating liquid may be further coated on the surface of the rice by 0.06 part by weight with respect to the weight of the rice.
코팅이 종료되면 상기 코팅된 쌀을 수분 함량이 15 내지 18중량%가 되도록 건조 단계를 더 포함할 수 있다.When the coating is completed, the coated rice may further be dried to have a water content of 15 to 18% by weight.
본 발명에서 제조된 쌀은 아래의 방법으로 밥을 지어 저항성 전분 함량을 강화시킬 수 있다.The rice produced in the present invention can be cooked in the following manner to enhance the resistant starch content.
일반적으로 밥을 하게 되면 쌀에는 100℃ 이상의 온도가 인가된다. 이 때 쌀 속에 포함된 전분 속의 아밀로오스와 코팅액은 수소 결합이 이루어지며, 이를 통하여 아밀로오스 내의 수소결합이 재형성되어 결합각도가 변화하게 된다. 기존 아밀로오스 수소결합 각도는 104.2℃이지만, 수소결합의 재형성을 통한 수소결합 각도는 104.7℃가 된다. 따라서, 전분을 분해하는 아밀라아제에 저항하게 되므로, 전분이 포도당으로 분해되지 않고 그대로 체외로 배출되게 된다.Generally, when rice is cooked, a temperature of 100 ° C or more is applied to rice. At this time, the amylose in the starch contained in the rice and the coating solution are hydrogen bonded, and the hydrogen bond in the amylose is reformed to change the bonding angle. The existing amylose hydrogen bonding angle is 104.2 ° C, but the hydrogen bonding angle through the reforming of the hydrogen bonding is 104.7 ° C. Therefore, since it resists amylase that decomposes starch, starch is not decomposed into glucose, but is discharged to the outside of the body as it is.
본 발명에 따른 저항전분 강화쌀을 활용하여 식사를 할 경우, 체내로 흡수되는 포도당의 양이 줄어들어 혈당량이 감소하고, 흡수되는 칼로리가 줄어들어 다이어트 효과를 가진다.When the rice is cooked using the resistant starch-reinforced rice according to the present invention, the amount of glucose absorbed into the body is reduced, the blood sugar level is decreased, and the calorie absorbed is reduced, thereby having a diet effect.
이상의 설명은 본 발명의 기술 사상을 예시적으로 설명한 것에 불과한 것으로서, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 수정 및 변형이 가능할 것이다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The foregoing description is merely illustrative of the technical idea of the present invention, and various changes and modifications may be made by those skilled in the art without departing from the essential characteristics of the present invention. Therefore, the embodiments disclosed in the present invention are intended to illustrate rather than limit the scope of the present invention, and the scope of the technical idea of the present invention is not limited by these embodiments. The scope of protection of the present invention should be construed according to the following claims, and all technical ideas within the scope of equivalents should be construed as falling within the scope of the present invention.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시 예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당 업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .
실시예Example 1. One.
스티그마스테롤 100 중량부를 기준으로, 베타시토스테롤 67 중량부, 캄페스테롤 100 중량부 및 세로토닌 67 중량부를 혼합하여 혼합물을 제조하였다. 여기서, 혼합 조성물의 평균입경은, 스티그마스테롤과 베타시토스테롤은 40nm이고, 캄페스테롤과 세로토닌은 80nm인 것을 사용하였다.67 parts by weight of beta-sitosterol, 100 parts by weight of campesterol, and 67 parts by weight of serotonin were mixed to prepare a mixture based on 100 parts by weight of stigmasterol. Here, the mean particle size of the mixed composition was 40 nm for stigmasterol and beta-sitosterol, and 80 nm for campesterol and serotonin.
이어서, 두께 0.3㎜, 지름 30㎝의 원판 모양인 실리콘 페이퍼(siliconpaper)를 준비하였다. 실시예에서 사용된 실리콘 페이퍼는 순도 99.9999999%의 단결정(單結晶) 규소를 얇게 잘라 표면을 매끈하게 다듬은 것을 구입하여 사용하였다. 그리고, 실리콘 페이퍼 위에 제조된 혼합물을 0.2mm 도포하였다. 혼합물이 도포된 실리콘 페이퍼에 파장 1,048nm, 주파수는 5.2Hz, 평균 출력 광전력 90W의 레이저를 3분간 조사하도록 하였다.Subsequently, silicon paper having a thickness of 0.3 mm and a diameter of 30 cm was prepared. The silicon paper used in the examples was prepared by cutting a thin single crystal silicon having a purity of 99.9999999% and smoothening the surface. Then, the mixture prepared on the silicone paper was applied to 0.2 mm. The silicon paper coated with the mixture was irradiated with a laser having a wavelength of 1,048 nm, a frequency of 5.2 Hz and an average output optical power of 90 W for 3 minutes.
그리고, 물과 혼합물을 1,000 : 1 중량비로 혼합한 다음, 교반기에 투입하여 500RPM으로 5분간 교반하여 쌀의 코팅액을 제조하였다.Then, the water and the mixture were mixed at a weight ratio of 1,000: 1, and then the mixture was added to a stirrer and stirred at 500 RPM for 5 minutes to prepare a coating solution of rice.
미리 세척한 일반 백미(白米)를 65℃로 건조하여 수분함량이 20중량%가 되도록 준비한 다음, 쌀과 코팅액을 1 : 0.04 중량비로 조절하여 쌀의 표면에 1차 분무하고, 1차 분무된 쌀의 표면에 코팅액을 0.06 중량비로 조절하여 2차 분무하였다. 2차 분무코팅된 쌀을 80℃에서 수분함량이 15중량%가 되도록 건조하여 쌀을 제조하였다.The preliminarily cleaned white rice was dried at 65 ° C to prepare a water content of 20% by weight. Then, the rice and the coating solution were adjusted to a weight ratio of 1: 0.04 to spray the rice first, Was sprayed to the surface of the coating liquid at a 0.06 weight ratio. The second spray-coated rice was dried at 80 ° C. to a water content of 15% by weight to prepare rice.
마지막으로, 앞서 제조된 쌀을 일반 전기밥솥에 200g 투입하여 밥을 지었다.Finally, 200 g of the above-prepared rice was put into a general rice cooker to cook rice.
비교예Comparative Example 1. One.
시중에서 판매되는 백미를 이용하여 일반 전기밥솥에 200g 투입하여 밥을 지었다.200 g of rice was put into a general rice cooker using commercially available white rice.
평가예Evaluation example 1. One. 저항전분Resistance starch 평가 evaluation
실시예 1과 비교예 1을 대상으로 AOAC Type을 통하여 측정하였다. 1.0g의 시료에 40ml 의 MES-Tris 완충용액(pH 8.2)을 넣어 잘 분산시킨다. Heat stable α-amylase(Cat No. A-3306, Sigma) 0.1ml을 넣어 끓는 수조(100℃)에서 저어주면서 15분간 반응시킨 후 실온으로 냉각시켰다. 여기에 Protease(Cat No. P-3910) 0.1ml (50mg/ml MES-Tris buffer)를 넣고 60℃ 항온 진탕기에서 30분간 반응시키고 여기에 HCl 5ml를 넣어 pH 4.6이 되도록 조정한 다음, amyloglucosidase(Cat No. A-9913, Sigma) 0.1ml를 가하고, 계속 60℃에서 30분간 반응시켰다. 반응을 멈추기 위해 총 알코올 농도 80%가 되도록 95% 에탄올을 첨가하고 1시간 이상 방치한 다음, 중량을 알고 있는 acid washed celite를 0.5g 정도 넣은 glass filter로 여과하였다. 95%와 78% 에탄올과 아세톤으로 씻고 불용성 잔사를 100±5℃ 오븐에서 원하는 함량이 될 때 까지 건조시켜, 중량을 측정하여 계산하였다.AOAC type was measured for Example 1 and Comparative Example 1. To 1.0 g of sample, 40 ml of MES-Tris buffer solution (pH 8.2) is added and dispersed well. 0.1 ml of heat stable α-amylase (Cat No. A-3306, Sigma) was added, and the mixture was allowed to react for 15 minutes while stirring in a boiling water bath (100 ° C.). To this, 0.1 ml (50 mg / ml MES-Tris buffer) of Protease (Cat No. P-3910) was added and the mixture was reacted for 30 minutes at 60 ° C on a shaking table for 30 minutes. Then, 5 ml of HCl was added thereto to adjust the pH to 4.6, and then amyloglucosidase Cat No. A-9913, Sigma) was added thereto, and the reaction was continued at 60 캜 for 30 minutes. To stop the reaction, 95% ethanol was added so that the total alcohol concentration was 80%, and the solution was allowed to stand for 1 hour or more. Then, the solution was filtered with a glass filter containing about 0.5 g of acid washed celite. Washed with 95% and 78% ethanol and acetone, and the insoluble residue was dried in a 100 ± 5 ° C oven until the desired content was obtained and the weight was measured and calculated.
저항전분의 생성률(%)= {불용성 잔사의 무게(g)/시료의 중량(g)} X 100Production rate (%) of resistant starch = {weight of insoluble residue (g) / weight of sample (g)} X 100
저항전분 생성률 결과를 아래의 표 1에 나타내었다.The results of the resistance starch production rate are shown in Table 1 below.
표 1을 살펴보면, 비교예 대비 실시예의 저항전분 생성률이 약 6배 이상 높게 나타나는 것을 알 수 있었다.As shown in Table 1, it was found that the resistance starch production rate of the Examples was about 6 times higher than that of the Comparative Examples.
따라서, 본 발명에 따라 제조된 쌀은 저항성 전분 함량을 향상시킨다는 것을 확인할 수 있었다.Thus, it was confirmed that the rice prepared according to the present invention improved the content of resistant starch.
Claims (4)
상기 코팅액을 파장은 1,040 내지 1,056nm이고, 주파수는 5.2 내지 5.6Hz, 평균 출력 광전력 85 내지 95W인 레이저로 2분 내지 10분 동안 처리하는 단계;
쌀의 표면에 상기 코팅액을 코팅하되, 쌀과 코팅액은 1 : 0.01 내지 0.2 중량비로 코팅하는 단계; 및
상기 코팅퇸 쌀의 수분 함량이 15 내지 18 중량%가 되도록 건조하는 단계를 포함하는 것을 특징으로 하는 저항성 전분 함량이 향상된 쌀의 제조방법.
Preparing a coating solution containing 30 to 80 parts by weight of betasitosterol, 90 to 120 parts by weight of campesterol and 30 to 80 parts by weight of serotonin based on 100 parts by weight of stigmasterol;
Treating the coating liquid with a laser having a wavelength of 1,040 to 1,056 nm, a frequency of 5.2 to 5.6 Hz and an average output optical power of 85 to 95 W for 2 to 10 minutes;
Coating the surface of the rice with the coating liquid, wherein the rice and the coating liquid are coated at a weight ratio of 1: 0.01 to 0.2; And
And drying the coated rice so that the moisture content of the coated rice is 15 to 18% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160159548A KR101798791B1 (en) | 2016-11-28 | 2016-11-28 | The manufacturing method for rice with enhanced resistant starch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160159548A KR101798791B1 (en) | 2016-11-28 | 2016-11-28 | The manufacturing method for rice with enhanced resistant starch |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101798791B1 true KR101798791B1 (en) | 2017-11-16 |
Family
ID=60806763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160159548A KR101798791B1 (en) | 2016-11-28 | 2016-11-28 | The manufacturing method for rice with enhanced resistant starch |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101798791B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190053528A (en) * | 2017-11-10 | 2019-05-20 | 김양희 | The Mixture for manufacturing of companion animal feeds having in blood sugar level |
-
2016
- 2016-11-28 KR KR1020160159548A patent/KR101798791B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190053528A (en) * | 2017-11-10 | 2019-05-20 | 김양희 | The Mixture for manufacturing of companion animal feeds having in blood sugar level |
KR102055983B1 (en) | 2017-11-10 | 2019-12-13 | 김양희 | The Mixture for manufacturing of companion animal feeds having in blood sugar level |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | Understanding the nutrient composition and nutritional functions of highland barley (Qingke): A review | |
Patel | Cereal bran fortified-functional foods for obesity and diabetes management: Triumphs, hurdles and possibilities | |
US5795606A (en) | Method for preparing a coated food | |
CN105132492B (en) | A kind of product of high resistant starch content and preparation method thereof of super-pressure coordinated enzyme preparation | |
AU713404B2 (en) | Coated food | |
CN105001343B (en) | One kind takes off branch using autoclaving collaboration enzyme process and prepares high-resistance starch (RS3) content product and preparation method thereof | |
CN109588695A (en) | A kind of preparation method of RS5 type wheat resistant starch | |
WO1988008257A1 (en) | Food facilitating bowel movement | |
CN108391692A (en) | A kind of production method of high microsteping beans short paste work goods | |
CN103609957A (en) | Nutritional porridge with effect of lowering blood lipid and blood glucose and preparation method thereof | |
CN108113002B (en) | Meal accompanying powder for reducing blood sugar response and fat absorption and preparation method thereof | |
KR101798791B1 (en) | The manufacturing method for rice with enhanced resistant starch | |
Plate et al. | The potential health benefits of corn components and products | |
CN105433363A (en) | Purple potato vermicelli and preparation method thereof | |
CN108095054B (en) | A plant capsule for reducing digestion and absorption of sugar in diet, and its preparation method | |
CN111642702A (en) | High dietary fiber and high protein chicken breast sausage suitable for diabetics and overweight people and preparation method thereof | |
Mabrouki et al. | Chemical, functional and nutritional characteristics of raw, autoclaved and germinated fenugreek seeds | |
JPH04112759A (en) | Modifying agent for rice cooking, cooked rice, modified rice and preparation of cooked rice | |
TW201026241A (en) | Product to reduce glycemic response of carbohydrate based foods | |
CN105410883A (en) | Celery vermicelli and preparation method of the celery vermicelli | |
JP2005328776A (en) | Rice for controlling rise of blood glucose level and processed food using the same | |
JP2018118967A (en) | Immuno-activator | |
KR101301926B1 (en) | INSTANT GRUEL FOR DIABETIC PATIENT AND METHOD FOR PRODUCING THE SAME,and INSTANT GRUEL FOR primix | |
CN107927731A (en) | A kind of brewed powder for reducing starch absorptivity and preparation method thereof | |
JP2966898B2 (en) | Food material and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |